The bilirubin blood test market is on track for substantial growth, with an expected increase of USD 552.66 million at a CAGR of 6.24% between 2023 and 2028. Driven by the rising prevalence of jaundice, liver diseases, and the growing demand for non-invasive diagnostic methods, the market is poised to expand significantly. This growth is further fueled by advancements in testing technology and a heightened awareness of the importance of early diagnosis and treatment of liver-related conditions.
For more details about the industry, get the PDF sample report for free
The Bilirubin Blood Test Market is witnessing significant growth, driven by the increasing prevalence of newborn jaundice and the rising need for bilirubin monitoring to prevent conditions such as kernicterus risk. Key applications include the detection and management of bilirubin concentration in infants, where early detection is critical for effective treatment, such as phototherapy treatment. Bilirubin assays and bilirubin panels are commonly used to measure bilirubin levels, enabling accurate bilirubin detection and helping to assess jaundice severity in neonatal testing. The market is also expanding with the availability of diagnostic kits and laboratory analyzers for bilirubin measurement, supporting pediatric diagnostics and assisting in bilirubin metabolism monitoring. The growing emphasis on rapid testing and invasive testing is driven by the need to identify bilirubin spikes and address bilirubin overload in newborns, while minimizing the risks of bilirubin toxicity and ensuring proper bilirubin clearance.
The bilirubin blood test is used to measure the levels of bilirubin in the blood—a yellow pigment produced during the breakdown of red blood cells. Elevated bilirubin levels can signal a variety of liver issues, such as hepatitis, liver disease, or gallbladder problems. The market is witnessing rapid growth, driven by an increased understanding of the importance of early diagnosis for conditions like neonatal jaundice, which affects many newborns.
Non-invasive techniques are gaining traction in the market, offering several advantages over traditional methods, including reduced patient discomfort and fewer complications. With jaundice being a common concern in infants, especially premature babies, the market is seeing a steady increase in demand for non-invasive bilirubin testing methods, such as transcutaneous bilirubin meters.
See What’s Inside: Access a Free Sample of Our In-Depth Market Research Report.
Several prominent companies are leading the way in the bilirubin blood test market by offering advanced diagnostic tools and solutions. These include both instruments and consumables, as well as portable testing kits. Companies are focusing on improving the accuracy, efficiency, and convenience of testing methods to meet the growing demand in pediatric clinics, research labs, and diagnostic centers.
Abbott Laboratories
Siemens AG
Thermo Fisher Scientific Inc.
Randox Laboratories Ltd.
Dragerwerk AG
Philips N.V.
F. Hoffmann La Roche Ltd.
These companies are enhancing their offerings through strategic partnerships and new product launches that focus on both non-invasive and benchtop testing technologies. With increasing consumer demand for accurate, fast, and affordable tests, these organizations are positioning themselves for long-term success in the market.
The bilirubin blood test market is segmented by end-users, product types, and geography. Understanding these segments helps identify where growth opportunities lie and how different regions and industries are adopting new diagnostic technologies.
Infants:
The infant segment is expected to witness the most significant growth, as neonatal jaundice affects approximately 80% of preterm infants. This segment is driven by increasing product availability, awareness programs, and government initiatives to combat neonatal jaundice. Bilirubin tests are essential for diagnosing and monitoring this condition to avoid complications like kernicterus.
Adults:
Bilirubin blood tests are also used for diagnosing a range of liver conditions in adults, including hepatitis, hemolytic anemia, and Gilbert’s syndrome. While the infant segment holds a dominant share, the adult market remains strong due to the rising global incidence of liver diseases.
Instruments:
Includes benchtop analyzers, bilirubin meters, and portable testing kits. The preference for non-invasive instruments is increasing, as they provide convenience and comfort to both patients and healthcare providers.
Consumables:
The consumables segment covers test strips, reagents, and other consumables used during bilirubin testing. The growth of this segment is linked to the rise in diagnostic tests globally.
Geography:
Several factors are driving the expansion of the bilirubin blood test market. These include the increasing demand for early detection and accurate diagnosis of liver diseases, a surge in the incidence of neonatal jaundice, and the growing preference for non-invasive diagnostic techniques.
Rising Prevalence of Liver Diseases: Conditions like hepatitis and liver cancer are contributing to higher demand for bilirubin blood tests. With increased awareness, patients and healthcare providers are focusing on early diagnosis to manage these diseases more effectively.
Growth in Neonatal Jaundice Cases: Approximately 80% of premature infants experience jaundice. This high prevalence makes neonatal jaundice a major driver of market growth, particularly in countries with high birth rates.
Non-Invasive Diagnostic Techniques: Non-invasive methods, such as transcutaneous bilirubinometers, are becoming more popular due to their ease of use, less discomfort, and minimal risk of complications.
Portable Testing Kits: The market is seeing increased demand for portable and easy-to-use bilirubin testing kits. These products enable healthcare workers to perform tests in remote areas or at the point of care, improving accessibility and diagnostic capabilities.
Technological Advancements: Advancements in diagnostic technology are enhancing the precision and efficiency of bilirubin blood tests, with companies investing heavily in research and development to create faster, more accurate diagnostic tools.
The bilirubin blood test market is experiencing significant growth across multiple regions. Each area has its own unique challenges and drivers that are contributing to the market's expansion.
North America is expected to dominate the market, contributing 38% to the global growth. The high prevalence of chronic liver diseases, strong healthcare infrastructure, and high insurance coverage are key drivers. The region's advanced medical technologies and widespread use of bilirubin testing instruments further solidify its position as the largest market for bilirubin blood tests.
In Europe, countries like Germany, the UK, and France are seeing rising demand for bilirubin blood tests. The aging population, along with increasing awareness of liver disease, is spurring market growth.
Asia is expected to be the fastest-growing region, driven by rising healthcare investments and increasing awareness of liver health in countries like China and India. The region is witnessing a surge in neonatal jaundice cases, which is boosting the demand for non-invasive bilirubin tests.
Get more details by ordering the complete report
Despite the promising market outlook, there are challenges that could hinder growth, particularly in emerging markets.
High Costs of Diagnostic Tests: Non-invasive diagnostic instruments, such as transcutaneous bilirubinometers, are often more expensive than traditional methods. This price barrier can limit access to tests, especially in low-income regions.
Complexity in Test Administration: Some advanced bilirubin tests, such as indirect and direct bilirubin tests, require skilled professionals to administer. This can be a challenge in areas with limited healthcare resources.
Regulatory Hurdles: The development and approval of new diagnostic tools can be slowed down by strict regulatory requirements, particularly in markets with rigorous healthcare standards like the US and EU.
Research into the bilirubin blood test sector highlights advances in bilirubin profiles and bilirubin binding mechanisms, aiding in more accurate diagnostic processes for liver damage and hepatic disorders. Increasing use of bilirubin detection techniques has enhanced the ability to diagnose bilirubin disorders early, improving testing accuracy and supporting bilirubin clearance monitoring. Neonatal bilirubin testing remains a priority, as it helps mitigate the risks associated with bilirubin excess and bilirubin toxicity in infants. As bilirubin levels are linked to hematologic conditions and liver enzymes, comprehensive bilirubin assays and bilirubin thresholds are critical for assessing liver bilirubin status and detecting bilirubin elevation. With continued focus on developing bilirubin standards and improving jaundice screening, the market is expected to grow steadily, with innovations in bilirubin monitoring contributing to more efficient and effective neonatal care.
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
